These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8667505)

  • 1. Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome.
    Slocum MM; Adams JG; Teel R; Spadone DP; Silver D
    J Vasc Surg; 1996 May; 23(5):839-43. PubMed ID: 8667505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
    Kikta MJ; Keller MP; Humphrey PW; Silver D
    Surgery; 1993 Oct; 114(4):705-10. PubMed ID: 7692613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apixaban as an alternate oral anticoagulant for the management of patients with heparin-induced thrombocytopenia.
    Walenga JM; Prechel M; Hoppensteadt D; Escalante V; Chaudhry T; Jeske WP; Bakhos M
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):482-7. PubMed ID: 23780399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
    Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
    Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the Fcγ Receptor II as a Possible Predisposing Factor for Heparin-Induced Thrombocytopenia.
    Slavik L; Svobodova G; Ulehlova J; Krcova V; Hlusi A; Prochazkova J; Hutyra M
    Clin Lab; 2015; 61(8):1027-32. PubMed ID: 26427148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome.
    Almeida JI; Coats R; Liem TK; Silver D
    J Vasc Surg; 1998 Feb; 27(2):309-14; discussion 315-6. PubMed ID: 9510285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
    Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
    Walenga JM; Prechel M; Jeske WP; Hoppensteadt D; Maddineni J; Iqbal O; Messmore HL; Bakhos M
    Br J Haematol; 2008 Oct; 143(1):92-9. PubMed ID: 18671707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of heparin-dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay.
    Leroux D; Canépa S; Viskov C; Mourier P; Herman F; Rollin J; Gruel Y; Pouplard C
    J Thromb Haemost; 2012 Mar; 10(3):430-6. PubMed ID: 22235911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
    Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
    Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): An 11-year experience.
    Palatianos G; Michalis A; Alivizatos P; Lacoumenda S; Geroulanos S; Karabinis A; Iliopoulou E; Soufla G; Kanthou C; Khoury M; Sfyrakis P; Stavridis G; Astras G; Vassili M; Antzaka C; Marathias K; Kriaras I; Tasouli A; Papadopoulos K; Katafygioti M; Matoula N; Angelidis A; Melissari E
    Am J Hematol; 2015 Jul; 90(7):608-17. PubMed ID: 25808486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies.
    Tonn ME; Schaiff RA; Kollef MH
    Ann Pharmacother; 1997 Mar; 31(3):323-6. PubMed ID: 9066940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia: current status and diagnostic challenges.
    Otis SA; Zehnder JL
    Am J Hematol; 2010 Sep; 85(9):700-6. PubMed ID: 20665476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of heparin-induced thrombocytopenia Type II in patients with subarachnoid hemorrhage treated with heparin versus enoxaparin.
    Kim GH; Hahn DK; Kellner CP; Komotar RJ; Starke R; Garrett MC; Yao J; Cleveland J; Mayer SA; Connolly ES
    J Neurosurg; 2009 Jan; 110(1):50-7. PubMed ID: 18976056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.
    Mousa SA; Ahmad S
    Am J Hematol; 2007 Apr; 82(4):276-82. PubMed ID: 17039513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.
    Ahmad S; Haas S; Hoppensteadt DA; Lietz H; Reid U; Bender N; Messmore HL; Misselwitz F; Bacher P; Gaikwad BS; Jeske WP; Walenga JM; Fareed J
    Thromb Res; 2002 Oct; 108(1):49-55. PubMed ID: 12586132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
    Matsuo T; Wanaka K; Asada R
    Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine monoclonal antibody to platelet factor 4/heparin complexes as a potential reference standard for platelet activation assays in heparin-induced thrombocytopenia.
    Asada R; Wanaka K; Walenga J; Prechel M; Miyashita K; Escalante V; Kaneko C; Hoshino N; Oosawa M; Matsuo M
    Clin Appl Thromb Hemost; 2013; 19(1):37-41. PubMed ID: 22826445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative thrombocytopenia in cardiac surgical patients - incidence of heparin-induced thrombocytopenia, morbidities and mortality.
    Thielmann M; Bunschkowski M; Tossios P; Selleng S; Marggraf G; Greinacher A; Jakob H; Massoudy P
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1391-5. PubMed ID: 20138779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.